NO-REFLOW PHENOMENON – MECHANISM, PREVENTION AND TREATMENT STRATEGIES
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5016Keywords:
No-Reflow Phenomenon, Acute Myocardial Infarction, Mechanism, TreatmentAbstract
No-reflow phenomenon is a major clinical problem in the treatment of acute myocardial infarction, which happens despite effective recanalization of the epicardial coronary arteries. It is also marked by compromised microvascular blood circulation and it is linked to poor clinical outcome, such as bigger infarct size, left ventricular remodeling and higher mortality rates. The lack of no-reflow pathophysiology is multifactorial in nature and consists of distal microthromboembolization, reperfusion injury, endothelial dysfunction, microvascular spasm, and excessive inflammatory response. The no-reflow diagnosis continues to be difficult. Angiographic techniques such as Thrombolysis In Myocardial Infarction (TIMI) flow grade, which are used widely, are not very effective in evaluating microvascular perfusion. Higher resolution imaging including cardiac magnetic resonance imaging, myocardial contrast echocardiography, among others, offer a more accurate analysis; nevertheless, their application in clinical practice is limited due to their infrequent availability and high cost. No-reflow phenomenon is also a complicated combating mechanism. The existing approaches to therapy are mainly directed at alleviating the burden of thrombus, limiting the area of infarction, and alleviating reperfusion damages. However, the efficacy of these methods is dynamic and inadequately frequently, and no single therapy aimed at the coronary microvascular dysfunction development is determined. This means that more investigations about the mechanism behind no-reflow, the creation of more sensitive diagnostic techniques, and specific treatment of no-reflow have to be taken to enhance microvascular reperfusion and patient outcome.
References
Abdel-Galeel, A., El-Zokaim, A., Hasan-Ali, H., Ibrahim, A., Ibrahim, A., & Ghaleb, R. (2021). Low ankle-brachial index is associated with microvascular coronary obstruction after primary PCI. Vascular Health and Risk Management, 17, 23–32. https://doi.org/10.2147/VHRM.S291658
Ahmad, M., Mehta, P., Reddivari, A. K. R., & Mungee, S. (2025). Percutaneous coronary intervention. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK556123/
Ali, Z. A., Landmesser, U., Maehara, A., Matsumura, M., Shlofmitz, R. A., Guagliumi, G., Price, M. J., Hill, J. M., Akasaka, T., Prati, F., Bezerra, H. G., Wijns, W., Leistner, D., Canova, P., Alfonso, F., Fabbiocchi, F., Dogan, O., McGreevy, R. J., McNutt, R. W., ... ILUMIEN IV Investigators. (2023). Optical coherence tomography-guided versus angiography-guided PCI. The New England Journal of Medicine, 389(16), 1466–1476. https://doi.org/10.1056/NEJMoa2305861
Annibali, G., Scrocca, I., Aranzulla, T. C., Meliga, E., Maiellaro, F., Musumeci, G., Annibali, G., Scrocca, I., Aranzulla, T. C., Meliga, E., Maiellaro, F., & Musumeci, G. (2022). “No-reflow” phenomenon: A contemporary review. Journal of Clinical Medicine, 11(8). https://doi.org/10.3390/jcm11082233
Basso, C., & Thiene, G. (2006). The pathophysiology of myocardial reperfusion: A pathologist’s perspective. Heart, 92(11), 1559–1562. https://doi.org/10.1136/hrt.2005.086959
Beijnink, C. W. H., Woelders, E. C. I., & van Geuns, R. J. M. (2023). No-reflow after primary PCI: Will distal intracoronary medication do the trick? Cardiovascular Revascularization Medicine, 47, 5–7. https://doi.org/10.1016/j.carrev.2022.12.002
Canu, M., Khouri, C., Marliere, S., Vautrin, E., Piliero, N., Ormezzano, O., Bertrand, B., Bouvaist, H., Riou, L., Djaileb, L., Charlon, C., Vanzetto, G., Roustit, M., & Barone-Rochette, G. (2022). Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLOS ONE, 17(5), e0268330. https://doi.org/10.1371/journal.pone.0268330
Carrick, D., Haig, C., Carberry, J., May, V. T. Y., McCartney, P., Welsh, P., Ahmed, N., McEntegart, M., Petrie, M. C., Eteiba, H., Lindsay, M., Hood, S., Watkins, S., Mahrous, A., Rauhalammi, S. M., Mordi, I., Ford, I., Radjenovic, A., Sattar, N., ... Berry, C. (2016). Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. https://doi.org/10.1172/jci.insight.85768
Celik, T., Ozturk, C., Balta, S., & Yildirim, A. O. (2016). Response to the letter regarding the article “Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention”. Cardiology Journal, 23(5), 589–590. https://doi.org/10.5603/CJ.2016.0083
Chen, S.-L., Zhang, J.-J., Han, Y., Kan, J., Chen, L., Qiu, C., Jiang, T., Tao, L., Zeng, H., Li, L., Xia, Y., Gao, C., Santoso, T., Paiboon, C., Wang, Y., Kwan, T. W., Ye, F., Tian, N., Liu, Z., ... Stone, G. W. (2017). Double kissing crush versus provisional stenting for left main distal bifurcation lesions: DKCRUSH-V randomized trial. Journal of the American College of Cardiology, 70(21), 2605–2617. https://doi.org/10.1016/j.jacc.2017.09.1066
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., Gale, C. P., Gilard, M., Jobs, A., Jüni, P., Lambrinou, E., Lewis, B. S., Mehilli, J., Meliga, E., Merkely, B., ... ESC Scientific Document Group. (2021). 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 42(14), 1289–1367. https://doi.org/10.1093/eurheartj/ehaa575
Dawson, L. P., Rashid, M., Dinh, D. T., Brennan, A., Bloom, J. E., Biswas, S., Lefkovits, J., Shaw, J. A., Chan, W., Clark, D. J., Oqueli, E., Hiew, C., Freeman, M., Taylor, A. J., Reid, C. M., Ajani, A. E., Kaye, D. M., Mamas, M. A., Stub, D., & MIG and BCIS Investigators. (2024). No-reflow prediction in acute coronary syndrome during percutaneous coronary intervention: The NORPACS risk score. Circulation: Cardiovascular Interventions, 17(4), e013738. https://doi.org/10.1161/CIRCINTERVENTIONS.123.013738
Doherty, D. J., Sykes, R., Mangion, K., & Berry, C. (2021). Predictors of microvascular reperfusion after myocardial infarction. Current Cardiology Reports, 23(3), 21. https://doi.org/10.1007/s11886-021-01442-1
Elgendy, I. Y., & Jneid, H. (2018). Microvascular obstruction in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: Another frontier to conquer? Journal of Thoracic Disease, 10(3), 1343–1346. https://doi.org/10.21037/jtd.2018.03.58
Galassi, A. R., Werner, G. S., Boukhris, M., Azzalini, L., Mashayekhi, K., Carlino, M., Avran, A., Konstantinidis, N. V., Grancini, L., Bryniarski, L., Garbo, R., Bozinovic, N., Gershlick, A. H., Rathore, S., Di Mario, C., Louvard, Y., Reifart, N., & Sianos, G. (2019). Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention, 15(2), 198–208. https://doi.org/10.4244/EIJ-D-18-00826
Geng, N., Ren, L., Xu, L., Zou, D., & Pang, W. (2021). Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders, 21(1), 488. https://doi.org/10.1186/s12872-021-02301-1
Goyal, A., Yu, F. T. H., Tenwalde, M. G., Chen, X., Althouse, A., Villanueva, F. S., & Pacella, J. J. (2017). Inertial cavitation ultrasound with microbubbles improves reperfusion efficacy when combined with tissue plasminogen activator in an in vitro model of microvascular obstruction. Ultrasound in Medicine & Biology, 43(7), 1391–1400. https://doi.org/10.1016/j.ultrasmedbio.2017.02.013
Heusch, G. (2019). Coronary microvascular obstruction: The new frontier in cardioprotection. Basic Research in Cardiology, 114(6), 45. https://doi.org/10.1007/s00395-019-0756-8
Hill, J. M., Kereiakes, D. J., Shlofmitz, R. A., Klein, A. J., Riley, R. F., Price, M. J., Herrmann, H. C., Bachinsky, W., Waksman, R., Stone, G. W., & Disrupt CAD III Investigators. (2020). Intravascular lithotripsy for treatment of severely calcified coronary artery disease. Journal of the American College of Cardiology, 76(22), 2635–2646. https://doi.org/10.1016/j.jacc.2020.09.603
Ibánez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., & Widimský, P. (2017a). 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Española de Cardiología, 70(12), 1082. https://doi.org/10.1016/j.rec.2017.11.010
Ibánez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., & Widimský, P. (2017b). 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Española de Cardiología, 70(12), 1082. https://doi.org/10.1016/j.rec.2017.11.010
Ito, H. (2001). No reflow phenomenon in coronary heart disease. Journal of Cardiology, 37(Suppl. 1), 39–42.
Jafari Afshar, E., Gholami, N., Samimisedeh, P., MozafaryBazargany, M., Tayebi, A., Memari, A., Yazdani, S., & Rastad, H. (2023). Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 10, 1295964. https://doi.org/10.3389/fcvm.2023.1295964
Jaffe, R., Dick, A., & Strauss, B. H. (2010). Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: A systematic approach. JACC: Cardiovascular Interventions, 3(7), 695–704. https://doi.org/10.1016/j.jcin.2010.05.004
Kalia, N. (2023). A historical review of experimental imaging of the beating heart coronary microcirculation in vivo. Journal of Anatomy, 242(1), 3–16. https://doi.org/10.1111/joa.13611
Karasu, M., Bolayır, H. A., Aktaş, İ., Karasu, M., Bolayır, H. A., & Aktaş, İ. (2024). Interleukin-34 as a robust predictor of no-reflow phenomenon in ST-elevation myocardial infarction: Insights into inflammatory mechanisms and clinical implications. Gazi Medical Journal. https://doi.org/10.12996/gmj.2024.4054
Kereiakes, D. J., Hill, J. M., Shlofmitz, R. A., Klein, A. J., Riley, R. F., Price, M. J., Herrmann, H. C., Bachinsky, W., Waksman, R., Stone, G. W., & Disrupt CAD III Investigators. (2022). Intravascular lithotripsy for treatment of severely calcified coronary lesions: 1-year results from the Disrupt CAD III study. Journal of the Society for Cardiovascular Angiography & Interventions, 1(1), 100001. https://doi.org/10.1016/j.jscai.2021.100001
Khattak, S., Townend, J. N., & Thomas, M. R. (2024). Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction. Frontiers in Molecular Biosciences, 11, 1287553. https://doi.org/10.3389/fmolb.2024.1287553
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., Ako, J., Arai, H., Ishii, H., Origuchi, H., Shimizu, W., Takemura, H., Tahara, Y., Morino, Y., Iino, K., ... Japanese Circulation Society Joint Working Group. (2019). JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circulation Journal, 83(5), 1085–1196. https://doi.org/10.1253/circj.CJ-19-0133
Kingma, J. G. (2018). Myocardial infarction: An overview of STEMI and NSTEMI physiopathology and treatment. World Journal of Cardiovascular Diseases, 8(11), 498–517. https://doi.org/10.4236/wjcd.2018.811049
Kloner, R. A., Brown, D. A., Csete, M., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017). New and revisited approaches to preserving the reperfused myocardium. Nature Reviews Cardiology, 14(11), 679–693. https://doi.org/10.1038/nrcardio.2017.102
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., ... ESC Scientific Document Group. (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477. https://doi.org/10.1093/eurheartj/ehz425
Li, H., Fu, D.-G., Liu, F.-Y., Zhou, H., & Li, X.-M. (2018). Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI. Experimental and Therapeutic Medicine, 15(4), 3940–3946. https://doi.org/10.3892/etm.2018.5900
Lim, S. Y., Bae, E. H., Jeong, M. H., Kang, D. G., Lee, Y. S., Kim, K. H., Lee, S. H., Yoon, K. H., Hong, S. N., Park, H. W., Hong, Y. J., Kim, J. H., Kim, W., Ahn, Y. K., Cho, J. G., Park, J. C., & Kang, J. C. (2004). Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circulation Journal, 68(10), 928–932. https://doi.org/10.1253/circj.68.928
Mahilmaran, A. (2023). Complications of PCI and its management. Indian Journal of Cardiovascular Disease in Women, 8(2), 99–109. https://doi.org/10.25259/IJCDW_20_2023
Mignatti, A., Echarte-Morales, J., Sturla, M., & Latib, A. (2025). State of the art of primary PCI: Present and future. Journal of Clinical Medicine, 14(2). https://doi.org/10.3390/jcm14020653
Ndrepepa, G., Colleran, R., & Kastrati, A. (2018). No-reflow after percutaneous coronary intervention: A correlate of poor outcome in both persistent and transient forms. EuroIntervention, 14(2), 139–141. https://doi.org/10.4244/EIJV14I2A21
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., Jüni, P., Kastrati, A., Koller, A., Kristensen, S. D., Niebauer, J., Richter, D. J., Seferovic, P. M., Sibbing, D., Stefanini, G. G., ... ESC Scientific Document Group. (2019). 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal, 40(2), 87–165. https://doi.org/10.1093/eurheartj/ehy394
Niccoli, G., Burzotta, F., Galiuto, L., & Crea, F. (2009). Myocardial no-reflow in humans. Journal of the American College of Cardiology, 54(4), 281–292. https://doi.org/10.1016/j.jacc.2009.03.054
Niccoli, G., Scalone, G., Lerman, A., & Crea, F. (2016). Coronary microvascular obstruction in acute myocardial infarction. European Heart Journal, 37(13), 1024–1033. https://doi.org/10.1093/eurheartj/ehv484
Pinelli, S., Agrinier, N., Bouchahda, N., Metzdorf, P. A., Camenzind, E., & Popovic, B. (2018). Myocardial reperfusion for acute myocardial infarction under an optimized antithrombotic medication: What can you expect in daily practice? Cardiovascular Revascularization Medicine, 19(7 Pt B), 820–825. https://doi.org/10.1016/j.carrev.2018.02.015
Qi, Q., Niu, J., Chen, T., Yin, H., Wang, T., & Jiang, Z. (2018). Intracoronary nicorandil and the prevention of the no-reflow phenomenon during primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Medical Science Monitor, 24, 2767–2776. https://doi.org/10.12659/MSM.906815
Ramjane, K., Han, L., & Jin, C. (2008). The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Experimental & Clinical Cardiology, 13(3), 121–128.
Rangel, F. O. D. (2021). Reperfusion strategies in acute myocardial infarction: State of the art. International Journal of Cardiovascular Sciences, 35(1), 113–122.
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., Davis, L. L., de Lemos, J. A., DeWald, T. A., Elgendy, I. Y., Feldman, D. N., Goyal, A., Isiadinso, I., Menon, V., Morrow, D. A., ... Williams, M. S. (2025). 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 151(13), e771–e862. https://doi.org/10.1161/CIR.0000000000001309
Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017). Acute myocardial infarction. Lancet, 389(10065), 197–210. https://doi.org/10.1016/S0140-6736(16)30677-8
Silva, M., Paiva, L., Teixeira, R., Ferreira, M. J., & Gonçalves, L. (2022). Microcirculation function assessment in acute myocardial infarction: A systematic review of microcirculatory resistance indices. Frontiers in Cardiovascular Medicine, 9, 1041444. https://doi.org/10.3389/fcvm.2022.1041444
Soukoulis, V., Boden, W. E., Smith, S. C., & O’Gara, P. T. (2014). Non-antithrombotic medical options in ACS: Old agents and new lines on the horizon. Circulation Research, 114(12), 1944–1958. https://doi.org/10.1161/CIRCRESAHA.114.302804
Srikanth, S., & Ambrose, J. A. (2012). Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI. Current Cardiology Reviews, 8(3), 168–176. https://doi.org/10.2174/157340312803217247
Stefanini, G. G., & Holmes, D. R. (2013). Drug-eluting coronary-artery stents. The New England Journal of Medicine, 368(3), 254–265. https://doi.org/10.1056/NEJMra1210816
Stone, G. W., Christiansen, E. H., Ali, Z. A., Andreasen, L. N., Maehara, A., Ahmad, Y., Landmesser, U., & Holm, N. R. (2024). Intravascular imaging-guided coronary drug-eluting stent implantation: An updated network meta-analysis. Lancet, 403(10429), 824–837. https://doi.org/10.1016/S0140-6736(23)02454-6
Sucato, V., Novo, G., Saladino, A., Evola, S., & Galassi, A. R. (2020). Coronary microvascular dysfunction. Minerva Cardioangiologica, 68(2), 153–163. https://doi.org/10.23736/S0026-4725.20.05070-7
Tan, Y., Yu, Y., Luo, J., Zhao, X., Liu, M., Li, M., Liu, W., Ma, X., & Shi, D. (2023). Global trends in research of coronary microvascular dysfunction over past two decades: A bibliometric analysis. Research Square. https://doi.org/10.21203/rs.3.rs-2767046/v1
Tomaniak, M., Kołtowski, Ł., Kochman, J., & Filipiak, K. J. (2013). Zjawiska slow-flow, no-reflow, dystalna embolizacja—Klasyfikacja, rokowanie i możliwości zapobiegania. Choroby Serca i Naczyń, 10(6), 315–321.
van Kranenburg, M., Magro, M., Thiele, H., de Waha, S., Eitel, I., Cochet, A., Cottin, Y., Atar, D., Buser, P., Wu, E., Lee, D., Bodi, V., Klug, G., Metzler, B., Delewi, R., Bernhardt, P., Rottbauer, W., Boersma, E., Zijlstra, F., & van Geuns, R.-J. (2014). Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC: Cardiovascular Imaging, 7(9), 930–939. https://doi.org/10.1016/j.jcmg.2014.05.010
Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., & Lima, J. A. (1998). Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation, 97(8), 765–772. https://doi.org/10.1161/01.cir.97.8.765
Xue, Y., Jian, S., Zhou, W., Zhou, Q., Xiang, J., Zhu, Y., Xiang, Z., Yang, H., Liu, G., & Luo, S. (2021). Associations of lipoprotein(a) with coronary atherosclerotic burden and all-cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Frontiers in Cardiovascular Medicine, 8, 638679. https://doi.org/10.3389/fcvm.2021.638679
Zhang, L., Lin, J., Luo, L., Liu, B., & Zeng, X. (2024). Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models. American Journal of Translational Research, 16(8), 3733–3741. https://doi.org/10.62347/ECNI6080
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Radosław Szydłowski, Magdalena Bodera, Anna Kaźmierska, Hanna Porwolik, Sonja Rozmus, Dominik Bylica
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
